Thursday, April 25

Rural Health-Tech Startup Raises Rs 3 Crore

Karma Healthcare, a health tech startup received Rs 3 crore as stock funds from early stage investment firm 1Crowd, existing investors comprising of Ankur Capital, Ennovent Capital and Beyond capital, and informal investors in a bid to scale operations and improve their technology.

“We are grateful to all our investors for reposing faith and commitment in our work. This new funding will help us scale our operations as well as enhance our technology offering to improve quality of care and provide great patient experience,” said Jagdeep Gambhir, CEO of Karma Healthcare.

 

The company aims at offering high-quality, cheat, equal and consistent healthcare to the under served population with a different business model. By combining the human care of a nurse and the potential of shared doctor services via real-time online video consultation, the company provides healthcare to customers via their e-Doctor clinics.

Karma Healthcare would like to bring a revolution in the country’s healthcare sector by setting up a pan India network of healthcare clinics. The firm is looking forward to make decisive development on a large scale and therefore reach their goal of providing “healthcare for all”.

The Rajasthan-based firm has already completed more than 50,000 consultations and are currently operating 10 e-Doctor clinics in Haryana and Rajasthan. The clinics offer a comprehensive set of clinical treatment, quality medicines and diagnostics at reasonable prices. The company is also backed by reputable organizations with the likes of Tata Trusts, UBS Optimus Foundation and WISH Foundation.

An online video medical consultancy

With their new funding, over 1 million patients coming from less under served communities of India will receive quality healthcare services through Karma’s e-Doctor service. The company has already developed an in-house technology program that helps in standardizing care, which includes a bespoke Clinical Decision Support System allowing the company to extend their competences to AI-driven diagnosis, treatment and monitoring.